Skip to content

Detection of FIT- , fecal- and mucosa associated microbiome and microRNA in patients with suspected colorectal adenomas or cancer

Detection of FIT- , fecal- and mucosa associated microbiome and microRNA in patients with suspected colorectal adenomas or cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27020
Enrollment
160
Registered
2017-08-28
Start date
2017-09-30
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microbiome, MicroRNA, Colorectal cancer, Adenomas

Interventions

The patient has to perform two FITs and one stool sample. One extra mucosal biopsy will be taken of found adenomas or CRC only in those patients undergoing a colonoscopy. A questionnaire about dietary

Sponsors

Erasmus Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Participants are between 50-75 years old. - Positive FIT in national CRC screening program - Suspicion of CRC - Willing to collect two FIT samples, one stool sample from one stool and fill out one Questionnaire

Exclusion criteria

Exclusion criteria: - Unwilling or not able to give informed consent

Design outcomes

Primary

MeasureTime frame
The main study parameter will be the analysis of the microbiome and miRNA profile in relation to colorectal cancer and adenomas.

Secondary

MeasureTime frame
- To assess the possibility of using the microbiome in a FIT as screening tool for CRC - To assess the possibility of using miRNA panels in a FIT as screening tool for CRC - To assess the difference in diversity and composition of the microbiome in FIT, stool sample and mucosal biopsy - To assess the difference in diversity and composition of miRNA in FIT, stool sample and mucosal biopsy

Contacts

Public ContactM.C.W. Spaander

Erasmus Medical Center Rotterdam

v.spaander@erasmusmc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)